Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.00)
# 1,786
Out of 4,639 analysts
1099
Total ratings
38.5%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintained: Buy | $60 | $38.98 | +53.93% | 30 | Aug 10, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $40 → $44 | $24.48 | +79.74% | 4 | Aug 10, 2026 | |
| TRVI Trevi Therapeutics | Initiated Coverage: Buy | $16 → $31 | $17.65 | +75.64% | 23 | Aug 7, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $12 → $14 | $6.58 | +112.93% | 4 | Aug 7, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $108 → $146 | $77.92 | +87.37% | 24 | Jul 31, 2026 | |
| AGEN Agenus | Maintained: Buy | $8 → $14 | $6.54 | +114.07% | 82 | Jul 30, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $170 | $109.50 | +55.25% | 1 | Jul 15, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $22 | $5.04 | +336.51% | 2 | Jun 30, 2026 | |
| KYMR Kymera Therapeutics | Rated: Buy | $117 → $155 | $108.32 | +43.09% | 4 | Jun 29, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $27 | $3.08 | +776.62% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $18.81 | +139.23% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $31.30 | +43.77% | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.95 | +127.85% | 9 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $18 | $7.82 | +130.18% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $17 | $16.94 | +0.37% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.2424 | +1,137.62% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $6.50 | +84.62% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $1.10 | +263.64% | 17 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $13.66 | +90.34% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $7.50 | +193.53% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $25.19 | +19.09% | 25 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $150 | $75.11 | +99.71% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $9.55 | +193.19% | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $33 | $20.20 | +63.37% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $49.98 | +10.04% | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.997 | +1,906.02% | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $11.17 | +284.94% | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $3.03 | +495.04% | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $34.09 | n/a | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $90.53 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $422 → $460 | $530.99 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $2 | $0.57999998 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $2 | $1.04 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $42.19 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.66 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.61 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.998 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $6.78 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $4.40 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9894 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0012 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.25 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.07 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.00 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.33 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.30 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $120 | $18.75 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $10 | $13.45 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $35.08 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.70 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.55 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.10 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5625 | n/a | 11 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.11 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 18 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.96 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.29 | n/a | 1 | May 12, 2020 |
Harrow
Aug 10, 2026
Maintained: Buy
Price Target: $60
Current: $38.98
Upside: +53.93%
Zymeworks
Aug 10, 2026
Maintained: Buy
Price Target: $40 → $44
Current: $24.48
Upside: +79.74%
Trevi Therapeutics
Aug 7, 2026
Initiated Coverage: Buy
Price Target: $16 → $31
Current: $17.65
Upside: +75.64%
Nuvation Bio
Aug 7, 2026
Maintained: Buy
Price Target: $12 → $14
Current: $6.58
Upside: +112.93%
Cytokinetics
Jul 31, 2026
Reiterated: Buy
Price Target: $108 → $146
Current: $77.92
Upside: +87.37%
Agenus
Jul 30, 2026
Maintained: Buy
Price Target: $8 → $14
Current: $6.54
Upside: +114.07%
Veradermics
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $109.50
Upside: +55.25%
Unicycive Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $22
Current: $5.04
Upside: +336.51%
Kymera Therapeutics
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $108.32
Upside: +43.09%
Elicio Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $3.08
Upside: +776.62%
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $18.81
Upside: +139.23%
May 29, 2026
Maintained: Buy
Price Target: $45
Current: $31.30
Upside: +43.77%
May 22, 2026
Maintained: Buy
Price Target: $9
Current: $3.95
Upside: +127.85%
Apr 9, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $7.82
Upside: +130.18%
Apr 7, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $16.94
Upside: +0.37%
Apr 7, 2026
Maintained: Buy
Price Target: $3
Current: $0.2424
Upside: +1,137.62%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $6.50
Upside: +84.62%
Mar 25, 2026
Maintained: Buy
Price Target: $3 → $4
Current: $1.10
Upside: +263.64%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $13.66
Upside: +90.34%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $7.50
Upside: +193.53%
Mar 13, 2026
Reiterated: Buy
Price Target: $30
Current: $25.19
Upside: +19.09%
Feb 23, 2026
Maintained: Buy
Price Target: $105 → $150
Current: $75.11
Upside: +99.71%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $9.55
Upside: +193.19%
Oct 3, 2025
Maintained: Buy
Price Target: $29 → $33
Current: $20.20
Upside: +63.37%
Sep 17, 2025
Maintained: Buy
Price Target: $53 → $55
Current: $49.98
Upside: +10.04%
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $0.997
Upside: +1,906.02%
Aug 19, 2025
Maintained: Buy
Price Target: $43
Current: $11.17
Upside: +284.94%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $3.03
Upside: +495.04%
Jul 15, 2025
Maintained: Buy
Price Target: $85
Current: $34.09
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $38
Current: $90.53
Upside: n/a
May 2, 2025
Maintained: Buy
Price Target: $422 → $460
Current: $530.99
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $0.57999998
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: $1.5 → $2
Current: $1.04
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $42.19
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $2.66
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.61
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.998
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $6.78
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $4.40
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.9894
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.0012
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.25
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.07
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Dec 15, 2022
Maintained: Buy
Price Target: $6
Current: $1.33
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.30
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $3 → $120
Current: $18.75
Upside: n/a
Mar 23, 2022
Maintained: Buy
Price Target: $17 → $10
Current: $13.45
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $67
Current: $35.08
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.70
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $7.55
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $3.10
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.5625
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.11
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $12.96
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $25.29
Upside: n/a